KPF
PKBO

K2 Principal Fund’s Peak Bio, Inc. Common Stock PKBO Stock Holding History

K2 Principal Fund’s Portfolio PKBO Stock Details PKBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-412,651
Closed -$4.02M – 428
2021
Q4 		$4.02M Hold
412,651
– – 0.27% 91
2021
Q3 		$4.04M Buy
412,651
+68,323
+20% +$663K 0.33% 87
2021
Q2 		$3.33M Buy
344,328
+200,892
+140% +$1.96M 0.28% 111
2021
Q1 		$1.38M Buy
+143,436
New +$1.39M 0.11% 191

Other funds holding PKBO

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
SFM
Spartan Fund Management Toronto, Ontario, Canada $30M AUM 11.98% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return

K2 Principal Fund's PKBO Position: Q1 2022 in Review

K2 Principal Fund sold out of Peak Bio, Inc. Common Stock (PKBO) in Q1 2022, closing a stake of 412,651 shares — an estimated $4.02M sold.

K2 Principal Fund first reported a position in PKBO in Q1 2021 and held it in 4 quarters. The position peaked at $4.04M in Q3 2021. 40 funds tracked by Wall St. Rank hold PKBO as of Q1 2022.

  • K2 Principal Fund reported no remaining Peak Bio, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • K2 Principal Fund sold 412,651 Peak Bio, Inc. Common Stock shares in Q1 2022, an estimated $4.02M.
  • K2 Principal Fund first reported a position in Peak Bio, Inc. Common Stock in Q1 2021 and held it in 4 quarters.
  • K2 Principal Fund's Peak Bio, Inc. Common Stock position peaked at $4.04M in Q3 2021.
  • 40 funds tracked by Wall St. Rank held Peak Bio, Inc. Common Stock as of Q1 2022.

Based on K2 Principal Fund's 13F filing for Q1 2022, filed 16 May 2022.